Tag: relating
AGRIPOWER: Declaration relating to the total number of voting rights and shares as of May 31, 2024 – 06/03/2024 at 6:00 p.m.
In accordance with the provisions of article L. 223-8 of the Commercial Code and article 223-16 of the General Regulations of the Financial Markets Authority: Date Total number of shares…
MICROPOLE: Press release making available to the public the response note and the “other information” document relating to the legal, financial and accounting characteristics of the company Micropole SA – 05/31/2024 at 5:55 p.m.
This press release does not constitute an offer to acquire and is not intended for distribution in jurisdictions where the Offer would not be authorized. PRESS RELEASE OF MAY 31,…
GeNeuro – Conditions for providing information relating to the general meeting of shareholders of June 12, 2024 – 05/29/2024 at 7:30 p.m.
Geneva, Switzerland, May 29, 2024 – 7:00 p.m. CEST – GeNeuro (Euronext Paris: CH0308403085 – GNRO), biopharmaceutical company developing new treatments for neurodegenerative and autoimmune diseases, such as multiple sclerosis…
OSMOZIS: Osmozis announces the signing of agreements relating to the acquisition of a majority block of Osmozis shares by the Passman Group following the favorable opinion of the Osmozis social and economic committee – 05/28/2024 at 7:00 p.m. 00
Press release Clapiers, May 28, 2024 Osmozis announces the signing of agreements relating to the acquisition of a majority block of Osmozis shares by the Passman Group following the favorable…
EXAIL TECHNOLOGIES (formerly GROUPE GORGE): Information relating to the total number of voting rights and shares making up the share capital on the date of the prior notice of meeting relating to the Ordinary General Meeting of June 18, 2024 – 05/13 /2024 at 7:00 p.m.
Paris, May 13, 2024 In accordance with article R.225-73-1 of the Commercial Code, the company Exail Technologies publishes below the total number of existing voting rights and the number of…
PRODWAYS: Information relating to the total number of voting rights and shares making up the share capital on the date of the prior notice of meeting relating to the Ordinary and Extraordinary General Meeting of June 18, 2024 – 05/13/2024 at 7 p.m. :00
May 13, 2024 In accordance with article R.22-10-23 of the Commercial Code, the company Prodways Group publishes below the total number of existing voting rights and the number of shares…
OSMOZIS: Monthly information relating to voting rights – 05/10/2024 at 6:00 p.m.
Clapiers, May 10, 2024 MONTHLY INFORMATION RELATING TO VOTING RIGHTS Pursuant to article 223-16 of the AMF General Regulations and article L.223-8 II of the Commercial Code. Reporting company: Company…
LHYFE: Information relating to the total number of shares and voting rights making up the share capital as of April 30, 2024 – 05/07/2024 at 6:00 p.m.
Nantes (France) – May 7, 2024 – 6:00 p.m. – Lhyfe (Euronext Paris – FR0014009YQ1 – LHYFE), independent producer of green hydrogen to decarbonize industry and mobility, informs of the…
MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF SHARES AND VOTING RIGHTS COMPOSING THE SHARE CAPITAL – 05/07/2024 at 6:05 p.m.
MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF SHARES AND VOTING RIGHTS COMPOSING THE SHARE CAPITAL – Closing date: April 30, 2024 Total number of shares making up the share…
MILIBOO: INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES COMPOSING THE SHARE CAPITAL – 05/03/2024 at 5:45 p.m.
Chavanod, May 3, 2024 – Miliboo (ISIN code: FR0013053535 – Mnemonic code: ALMLB), publishes the number of shares making up its capital and the total number of voting rights (articles…
BOGART: MONTHLY INFORMATION RELATING TO VOTING RIGHTS – 05/03/2024 at 6:55 p.m.
PRESS RELEASE Paris, May 3, 2024 ART. L233-8-II of the commercial code and ART 222-12-5 of the AMF general regulations Company name of issuer: JBOG Nature of securities: ISIN FR0012872141…
PHARNEXT: Information relating to the total number of voting rights and shares making up the share capital – 05/02/2024 at 6:30 p.m.
Suresnes, France, May 2, 2024 at 6:30 p.m. (CET) – Pharnext SCA (FR001400N1P4– ALPHA) (the “Company”), a biopharmaceutical company at an advanced clinical stage developing new therapies for neurodegenerative diseases…